Uncovering the Novel Role of NR1D1 in Regulating BNIP3-Mediated Mitophagy in Ulcerative Colitis

• Published in: International journal of molecular sciences 2023-09, Vol.24 (18), p.14222
• Main Authors: Chen, Yidong, Li, Junrong, Li, Shuang, Cheng, Yiyu, Fu, Xiaoyu, Li, Jiamin, Zhu, Liangru
• Format: Article
• Language: English
• Subjects: Analysis; Antigens; Apoptosis; Autophagy; BNIP3; Chromatin; circadian clock; Circadian rhythm; Dextran; Disease; Gene expression; Genes; Health aspects; Homeostasis; Inflammation; Inflammatory bowel disease; Metabolism; Microorganisms; Mitochondria; mitophagy; NR1D1; Pathogenesis; Pathophysiology; Proteins; Quality control; Reactive oxygen species; RNA sequencing; Signal transduction; Ulcerative colitis
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms241814222

Background: Ulcerative colitis (UC) is a chronic, incurable condition characterized by mucosal inflammation and intestinal epithelial cell (IEC) damage. The circadian clock gene NR1D1, implicated in UC and the critical mitophagy process for epithelial repair, needs further exploration regarding its role in mitophagy regulation in UC. Methods: We created a jet lag mouse model and induced colitis with dextran sulfate sodium (DSS), investigating NR1D1’s role. Intestinal-specific Nr1d1 knockout mice were also generated. RNA sequencing, chromatin immunoprecipitation (ChIP), and dual-luciferase reporter assays helped ascertain NR1D1’s regulatory effect on BNIP3 expression. The mitochondrial state in IECs was assessed through transmission electron microscopy, while confocal microscopy evaluated mitophagy-associated protein expression in colon tissue and CCD841 cells. Cell apoptosis and reactive oxygen species (ROS) were measured via flow cytometry. Results: We observed reduced NR1D1 expression in the IECs of UC patients, accentuated under jet lag and DSS exposure in mice. NR1D1 ablation led to disrupted immune homeostasis and declined mitophagy in IECs. NR1D1, usually a transcriptional repressor, was a positive regulator of BNIP3 expression, leading to impaired mitophagy, cellular inflammation, and apoptosis. Administering the NR1D1 agonist SR9009 ameliorated colitis symptoms, primarily by rectifying defective mitophagy. Conclusions: Our results suggest that NR1D1 bridges the circadian clock and UC, controlling BNIP3-mediated mitophagy and representing a potential therapeutic target. Its agonist, SR9009, shows promise in UC symptom alleviation.